TetraLogic Pharmaceuticals Corporation
TLOG
$0.00
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.47M | 2.38M | 2.97M | 2.56M | 2.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.43M | 3.88M | 6.27M | 9.71M | 8.62M |
| Operating Income | -1.43M | -3.88M | -6.27M | -9.71M | -8.62M |
| Income Before Tax | -10.95M | -6.75M | -11.07M | -14.27M | -10.90M |
| Income Tax Expenses | -2.32M | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.63M | -6.75M | -11.07M | -14.27M | -10.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.63M | -6.75M | -11.07M | -14.27M | -10.90M |
| EBIT | -1.43M | -3.88M | -6.27M | -9.71M | -8.62M |
| EBITDA | -1.42M | -3.86M | -6.20M | -9.66M | -8.57M |
| EPS Basic | -0.35 | -0.27 | -0.45 | -0.58 | -0.46 |
| Normalized Basic EPS | -0.08 | -0.14 | -0.20 | -0.28 | -0.26 |
| EPS Diluted | -0.35 | -0.27 | -0.45 | -0.58 | -0.46 |
| Normalized Diluted EPS | -0.08 | -0.14 | -0.20 | -0.28 | -0.26 |
| Average Basic Shares Outstanding | 24.77M | 24.77M | 24.77M | 24.78M | 23.83M |
| Average Diluted Shares Outstanding | 24.77M | 24.77M | 24.77M | 24.78M | 23.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |